Yang Chao, Sun Liang, Li Xinghan, Xie Li, Yu Mei, Feng Lian, Jiang Zongting, Guo Weihua, Tian Weidong
1 National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University , Chengdu, 610041, China .
Cell Reprogram. 2014 Oct;16(5):379-91. doi: 10.1089/cell.2014.0026. Epub 2014 Jul 29.
Trauma or degenerative diseases of the central nervous system (CNS) cause the loss of neurons or glial cells. Stem cell transplantation has become a vital strategy for CNS regeneration. It is necessary to effectively induce nonneurogenic stem cells to differentiate into neurogenic cell lineages because of the limited source of neurogenic stem cells, relatively difficult cultivation, and ethical issues. Previous studies have found that dental stem cells can be used for transplantation therapy. The aim of this study was to explore a better inductive mode and time point for dental stem cells to differentiate into neural-like cells and evaluate a better candidate cell. In this study, dental follicle stem cells (DFSCs), dental papilla stem cells (DPSCs), and stem cells from apical papilla (SCAPs) were cultivated in five different modes. The proliferation ability, morphology, and expression of neural marker genes were analyzed. Results showed that DFSCs showed a higher proliferation potential. The proliferation was decreased after cultivation in chemical inductive medium as cultivation modes 3 and 5. The cells could present neural-like cell morphology after cultivation with human epidermal growth factor (EGF) and fibroblast growth factor-basic (bFGF) as cultivation modes 4 and 5. The vast majority of DFSCs gene expression levels in mode 4 on the third day was upregulated significantly. In conclusion, our data suggested that different dental stem cells exhibited different neural differentiation potentials. DFSCs might be the better candidate cell type. Furthermore, cultivation mode 4 and timing of the third day may promote differentiation into neurogenic cell lineages more effectively before transplantation to treat neurological diseases.
中枢神经系统(CNS)的创伤或退行性疾病会导致神经元或神经胶质细胞的丧失。干细胞移植已成为中枢神经系统再生的重要策略。由于神经源性干细胞来源有限、培养相对困难以及伦理问题,有效诱导非神经源性干细胞分化为神经源性细胞谱系是必要的。先前的研究发现,牙源性干细胞可用于移植治疗。本研究的目的是探索牙源性干细胞分化为神经样细胞的更好诱导模式和时间点,并评估更好的候选细胞。在本研究中,牙囊干细胞(DFSCs)、牙髓干细胞(DPSCs)和根尖乳头干细胞(SCAPs)以五种不同模式进行培养。分析了其增殖能力、形态以及神经标记基因的表达。结果显示,DFSCs表现出更高的增殖潜力。在化学诱导培养基(培养模式3和5)中培养后增殖能力下降。在用人表皮生长因子(EGF)和成纤维细胞生长因子-碱性(bFGF)培养(培养模式4和5)后,细胞可呈现神经样细胞形态。在第3天,模式4中绝大多数DFSCs的基因表达水平显著上调。总之,我们的数据表明,不同的牙源性干细胞表现出不同的神经分化潜能。DFSCs可能是更好的候选细胞类型。此外,培养模式4和第3天的时间点可能在移植治疗神经疾病前更有效地促进其向神经源性细胞谱系分化。